Charles Reed

Charles Reed is an Assistant Professor of Biology in the Department of Natural and Applied Science at Alvernia University. His professional background includes:

• Current academic position at Alvernia University
• Former Research Assistant Professor at Thomas Jefferson University
• Industry leadership as Senior Director in multiple biotechnology companies

With over 20 years of specialized experience, his research focuses on structural biology and protein engineering applications in recombinant therapeutic proteins, cell and gene therapies, vaccine development, and cancer immunotherapies. He is the co-inventor of INO-3107, a therapeutic vaccine for recurrent respiratory papillomatosis (RRP), currently in final-stage clinical testing with FDA Biologics License Application expected in 2025.

Dr. Reed holds multiple patents in molecular biology, protein engineering, and antibody design. He maintains dual roles as a university educator and independent biotechnology consultant specializing in protein design, bridging academic research with industrial biotechnology applications.